As of 2023, the global Metformin Drugs Market was valued at approximately USD 3,784 million. However, market projections indicate a decline, with the market expected to reach USD 2,252.68 million by 2032. This represents a negative compound annual growth rate (CAGR) of -0.06% over the forecast period. North America accounted for USD 893.62 million in 2023, with a projected CAGR of -0.05% through..
